-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Initiates Coverage On Ascentage Pharma Group with Market Outperform Rating, Announces Price Target of $35

Benzinga·10/13/2026 12:41:01
Diffusion vocale
Citizens analyst Silvan Turkcan initiates coverage on Ascentage Pharma Group (NASDAQ:AAPG) with a Market Outperform rating and announces Price Target of $35.